Susquehanna International Group’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

Susquehanna International Group’s Portfolio JNP Stock Details JNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-42,800	Closed	-$203K	–	10245
2017 Q1	$203K	Buy	+42,800	New	+$216K	﹤0.01%	7989
2016 Q3	–	Sell	-17,200	Closed	-$121K	–	9419
2016 Q2	$121K	Sell	17,200 -18,800	-52%	-$132K	﹤0.01%	7934
2016 Q1	$238K	Buy	+36,000	New	+$265K	﹤0.01%	7665
2015 Q4	–	Sell	-26,800	Closed	-$316K	–	10324
2015 Q3	$316K	Sell	26,800 -21,700	-45%	-$240K	﹤0.01%	7951
2015 Q2	$444K	Buy	48,500 +200	+0.4%	+$1.51K	﹤0.01%	7857
2015 Q1	$300K	Buy	+48,300	New	+$299K	﹤0.01%	7982
2014 Q4	–	Sell	-33,700	Closed	-$198K	–	10367
2014 Q3	$198K	Buy	+33,700	New	+$206K	﹤0.01%	8694
2014 Q2	–	Sell	-59,800	Closed	-$432K	–	10307
2014 Q1	$432K	Buy	+59,800	New	+$413K	﹤0.01%	6982

Susquehanna International Group's JNP Position: Q3 2018 in Review

Susquehanna International Group sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q3 2018, closing a stake of 32,450 shares — an estimated $282K sold.

Susquehanna International Group first reported a position in JNP in Q1 2015 and held it in 9 quarters. The position peaked at $686K in Q3 2015. 0 funds tracked by Wall St. Rank hold JNP as of Q3 2018.

Susquehanna International Group reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
Susquehanna International Group sold 32,450 Juniper Pharmaceuticals, Inc. Common Stock shares in Q3 2018, an estimated $282K.
Susquehanna International Group first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q1 2015 and held it in 9 quarters.
Susquehanna International Group's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $686K in Q3 2015.
0 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q3 2018.

Based on Susquehanna International Group's 13F filing for Q3 2018, filed 14 Nov 2018.